Chinook Therapeutics Inc Cvr (ADRO)
R&D Expense Growth
-11.59%
Fiscal year · Period ending:
ADRO R&D Expense Growth
Latest reported-11.59%period ending
Latest reported-11.59%period ending
ADRO FY R&D Growth (YoY) (0.00% → -11.59%)
Latest values, visible window
High-resolution chart · PNG
ADRO r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -11.5921% | |
| -15.1552% | |
| 1.897% | |
| 49.5644% | |
| 149.4322% | |
| 120.015% | |
| 0% |